Log in to save to my catalogue

A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral resp...

A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral resp...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_49be1a7c59ce424ebe2aec3017429a3e

A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral responses

About this item

Full title

A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral responses

Publisher

London: Nature Publishing Group UK

Journal title

npj vaccines, 2025-03, Vol.10 (1), p.49-11, Article 49

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Herpes zoster (HZ) is a painful vesicular rash that occurs upon varicella-zoster virus (VZV) reactivation in older adults and immunocompromised individuals. Although there is currently an approved vaccine for the prevention of shingles, its administration is commonly associated with high reactogenicity. This highlights the need to develop new vacci...

Alternative Titles

Full title

A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral responses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_49be1a7c59ce424ebe2aec3017429a3e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_49be1a7c59ce424ebe2aec3017429a3e

Other Identifiers

ISSN

2059-0105

E-ISSN

2059-0105

DOI

10.1038/s41541-025-01093-1

How to access this item